0.9569

4.01% 0.0369

After Hours: .97 0.0131 +1.37%

Citius Oncology Inc (CTOR)

Overview News Price History Discussions Forecast

Citius Oncology Inc stock is traded at $0.9569, with a volume of 29,188. It is up +4.01% in the last 24 hours and up +36.12% over the past month. Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Previous Close:

$0.92

Open:

$0.93

24h Volume:

29,188

Relative Volume:

0.12

Market Cap:

$84.47M

Revenue:

Net Income/Loss:

$-23.64M

P/E Ratio:

-3.1058

EPS:

-0.3081

Net Cash Flow:

$-12.89M

1W Performance:

+10.38%

1M Performance:

+36.12%

6M Performance:

-37.86%

1Y Performance:

+8.74%

1-Day Range:

$0.8823

$0.9649

1-Week Range:

$0.8051

$0.9898

52-Week Range:

$0.4912

$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name

Citius Oncology Inc

Sector

Healthcare (1106)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(908) 967-6677

Address

11 COMMERCE DRIVE, CRANFORD

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CTOR's Discussions on Twitter

Compare CTOR vs TAK, ZTS, TEVA, HLN, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTOR Citius Oncology Inc	0.9569	81.21M	0	-23.64M	-12.89M	-0.3081
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-23-25	Upgrade	Maxim Group	Hold → Buy
Nov-27-24	Initiated	Maxim Group	Buy

Citius Oncology Inc Stock (CTOR) Latest News

May 05, 2026

Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization - PR Newswire

May 05, 2026

May 03, 2026

Citius Oncology Faces Nasdaq Non-Compliance, Delisting Risk Looms - TipRanks

May 03, 2026

May 01, 2026

CTXR Stock Price, Quote & Chart | CITIUS PHARMACEUTICALS INC (NASDAQ:CTXR) - ChartMill

May 01, 2026

Apr 30, 2026

Citius Oncology ships first international order of LYMPHIR to Europe - TradingView

Apr 29, 2026

Citius Oncology Ships First International Order of LYMPHIR™ to Europe - Nasdaq

Apr 29, 2026

CTOR Stock Price, Quote & Chart | CITIUS ONCOLOGY INC (NASDAQ:CTOR) - ChartMill

Apr 29, 2026

Apr 28, 2026

Citius Oncology, Inc. Receives Nasdaq Compliance Notice for CTOR Common Stock – Form 8-K April 2026 Filing - Minichart

Apr 28, 2026

Citius Oncology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Apr 28, 2026

Nasdaq warns Citius Oncology (NASDAQ: CTOR) on sub-$1 bid price and delisting risk - Stock Titan

Apr 28, 2026

Apr 27, 2026

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - marketscreener.com

Apr 27, 2026

Apr 23, 2026

Citius Oncology announces pricing of $9 million public offering - MSN

Apr 23, 2026

Apr 18, 2026

Working capital per share of Citius Oncology, Inc. – NASDAQ:CTOR - TradingView

Apr 18, 2026

Citius Oncology (NASDAQ:CTOR) Trading 9% HigherWhat's Next? - MarketBeat

Apr 18, 2026

Apr 17, 2026

CTOR Technical Analysis | Trend, Signals & Chart Patterns | CITIUS ONCOLOGY INC (NASDAQ:CTOR) - ChartMill

Apr 17, 2026

Apr 15, 2026

Breakeven On The Horizon For Citius Oncology, Inc. (NASDAQ:CTOR) - Yahoo Finance

Apr 15, 2026

Apr 13, 2026

Aug Retail: Can Citius Oncology Inc lead its sector in growth2026 Dividend Review & AI Driven Stock Price Forecasts - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

What is the growth rate of Citius Oncol (CTOR) Stock | Price at $0.65, Down 1.52%Stock Entry Points - Xã Vĩnh Công

Apr 10, 2026

Apr 07, 2026